DE3884402T2 - Nootropik. - Google Patents

Nootropik.

Info

Publication number
DE3884402T2
DE3884402T2 DE88903353T DE3884402T DE3884402T2 DE 3884402 T2 DE3884402 T2 DE 3884402T2 DE 88903353 T DE88903353 T DE 88903353T DE 3884402 T DE3884402 T DE 3884402T DE 3884402 T2 DE3884402 T2 DE 3884402T2
Authority
DE
Germany
Prior art keywords
present
administration
compound
trh
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88903353T
Other languages
German (de)
English (en)
Other versions
DE3884402D1 (en
Inventor
Kiyoshi Nippon Shinyaku Kimura
Yutaka Nippon Shinyak Nakagawa
Takashi Nippon Shiny Ogasawara
Yojiro Nippon Shinyaku Co Ukai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grünenthal GmbH
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of DE3884402D1 publication Critical patent/DE3884402D1/de
Application granted granted Critical
Publication of DE3884402T2 publication Critical patent/DE3884402T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE88903353T 1987-04-08 1988-04-07 Nootropik. Expired - Fee Related DE3884402T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8640587 1987-04-08

Publications (2)

Publication Number Publication Date
DE3884402D1 DE3884402D1 (en) 1993-10-28
DE3884402T2 true DE3884402T2 (de) 1994-03-03

Family

ID=13885954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88903353T Expired - Fee Related DE3884402T2 (de) 1987-04-08 1988-04-07 Nootropik.

Country Status (10)

Country Link
US (1) US4956364A (enExample)
EP (1) EP0382842B1 (enExample)
KR (1) KR960002182B1 (enExample)
CH (1) CH673654A5 (enExample)
DE (1) DE3884402T2 (enExample)
DK (1) DK681288A (enExample)
GB (1) GB2219501B (enExample)
NL (1) NL8820210A (enExample)
SE (1) SE8804431L (enExample)
WO (1) WO1988007867A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT63609A (en) * 1992-03-10 1993-09-28 Sandoz Ag Process for producing new derivatives and isosters of beta-amino acids and pharmaceutical compositions comprising such compounds
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865934A (en) * 1973-04-02 1975-02-11 Abbott Lab Method of enhancing memory and learning
JPS59225182A (ja) * 1983-03-25 1984-12-18 Yamanouchi Pharmaceut Co Ltd ２−アゼチジノン−４−カルボン酸の誘導体
DE3502041A1 (de) * 1985-01-23 1986-07-24 Grünenthal GmbH, 5190 Stolberg Verwendung von dipeptidderivaten zur behandlung posttraumatischer nervenschaeden
JPH06110578A (ja) * 1992-09-30 1994-04-22 Hitachi Ltd ペン入力情報処理装置
JPH06233198A (ja) * 1993-02-03 1994-08-19 Nippon Telegr & Teleph Corp <Ntt> 複数のイメージセンサを持つ画像入力装置

Also Published As

Publication number Publication date
WO1988007867A1 (fr) 1988-10-20
SE8804431D0 (sv) 1988-12-08
EP0382842B1 (en) 1993-09-22
EP0382842A4 (en) 1990-12-05
US4956364A (en) 1990-09-11
GB2219501B (en) 1990-09-26
GB8827321D0 (en) 1988-12-29
KR960002182B1 (ko) 1996-02-13
NL8820210A (nl) 1989-03-01
DK681288D0 (da) 1988-12-07
DK681288A (da) 1988-12-07
EP0382842A1 (en) 1990-08-22
AU1576488A (en) 1988-11-04
DE3884402D1 (en) 1993-10-28
KR890700354A (ko) 1989-04-24
SE8804431L (sv) 1988-12-08
GB2219501A (en) 1989-12-13
CH673654A5 (enExample) 1990-03-30
AU619464B2 (en) 1992-01-30

Similar Documents

Publication Publication Date Title
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE69802543T2 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
EP0188810B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Verhinderung oder Behandlung posttraumatischer Nervenschäden nach unfallbedingten Rückenmarks- und/oder Gehirntraumen
DE2856393A1 (de) Mittel zur behandlung des zentralnervensystems
DD223360A5 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE69027220T2 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE60013466T2 (de) Im mund zerfallende zusammensetzung mit mirtazapin
EP1239862B1 (de) Pharmazeutische zubereitung enthaltend zytostatika und elektronenakzeptoren zur behandlung von krebs
DE2950154C2 (enExample)
DE69115102T2 (de) Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren.
EP1001756A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE69624935T2 (de) Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden
AT392002B (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
DE69113062T2 (de) Pharmazeutische zusammensetzungen.
DE2755017C2 (enExample)
EP0417637A2 (de) Verwendung von Dopamin-Autorezeptor-Agonisten bei der Behandlung von Drogenabhängigkeit
US4956364A (en) Nootropic agent
DE69424779T2 (de) Verwendung von triazinverbindungen bei angstzuständen
DE2117762A1 (de) Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
DE3820817C2 (de) Antileptikum
DE2823267C2 (enExample)
DE2743702A1 (de) Abmagerungs- oder schlankmacher- zubereitung und verfahren zu ihrer herstellung
DE3904795A1 (de) Pharmazeutisches praeparat und diagnoseverfahren
DE4023136A1 (de) Neue galenische, orale form zur verbesserung der bioverfuegbarkeit von medikamenten

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: GRUENENTHAL GMBH, 52078 AACHEN, DE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee